Tord Lendau

Chairman of Boards Drive plans and change

📍 Stockholm County, Sweden🔄 Updated October 2026💼 5 investments📅 22 years investing🗓 Last invested Feb 2022𝕏 @upgrade_to_unlock
VC🌍 Sweden
5
Total investments
1
Early stage
0
Mid stage
1
Late stage
22y
Years active

Portfolio

4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Feb 2022
Again is the first consumer survey solution built on top of Open Banking, where surveys and consumer spending data has been integrated into one single platform to create a more fine-grained, accurate and actionable understanding of consumers. With an extensive and rapidly growing database of verified consumers and 20 million card transactions to date, Again offers agencies and brands unparalleled opportunities compared to traditional survey solutions: 1) Fine-grained view of consumer behavior Consumer spending data goes beyond what can be captured through surveys alone. By allowing survey results to be analyzed through a lens of respondents’ spending data, we enable a more reality-based understanding of consumer preferences, opinions and decision-making processes. 2) Higher Marketing ROI By running survey responses against spending data, we uncover how factors like brand perception, ad exposure, or product features influence purchasing decisions within different target groups. With this knowledge, our customers refine their strategies to better resonate with specific audiences, leading to improved targeting and higher returns on investment. 3) Precision & Accuracy Utilizing consumer spending data, marketers can precisely select survey participants based on their actual spending behavior and verified demographic variables. This allows for swift construction of highly specific samples, and ensures accuracy throughout the survey process.
Board Member at the Swedish Nanotech Association
Feb 2018
SwedNanoTech är en paraplyorganisation för svenska aktörer verksamma inom nanoteknik. Vi arbetar för att påverka, skapa mötesplatser och bygga broar mellan akademi, industri, näringsliv och allmänhet för en ansvarsfull och säker utveckling av nanoteknologi.
Member of the Board MedTech, Medical device strategy activation stockholm
May 2014
Boule Diagnostics develops and manufactures diagnostic instruments and consumables for healthcare providers worldwide. The company’s primary focus is in small to medium-sized hospitals, clinics, and laboratories in both human and veterinary diagnostics. Boule has a strong heritage when it comes to hematology diagnostics. Our blood tests help provide one of the first and most important indicators of a disease state and Boule systems play an increasingly role in helping build the infrastructure of healthcare for small and medium size patient care environments in both human and veterinary diagnostic markets. Boule operates via subsidiaries in Sweden, the USA, Mexico and Russia. The company products are sold globally primarily through more than 200 distributors and partners in more than 100 countries, supported by Boule’s own local sales and support personnel. The Boule shares are listed on Nasdaq Stockholm since 2011
Member of the Board
2004
ArthroCare develops and manufactures surgical devices, instruments, and implants that strive to enhance surgical techniques as well as improve patient outcomes. Its devices improve many existing surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its internationally patented Coblation (R) technology. This technology precisely dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology including its OPUS (R) line of fixation products as well as re-usable surgical instruments. ArthroCare is leveraging these technologies in order to offer a comprehensive line of surgical devices to capitalize on a multi-billion dollar market opportunity across several surgical specialties, including its two core product areas consisting of Sports Medicine and Ear, Nose, and Throat as well as other areas such as spine, wound care, urology and gynecology.
Experience · 8 entries
All (8)
Investments (5)
Board (4)
2022
Angel Investor
Feb 2022
Again is the first consumer survey solution built on top of Open Banking, where surveys and consumer spending data has been integrated into one single platform to create a more fine-grained, accurate and actionable understanding of consumers. With an extensive and rapidly growing database of verified consumers and 20 million card transactions to date, Again offers agencies and brands unparalleled opportunities compared to traditional survey solutions: 1) Fine-grained view of consumer behavior Consumer spending data goes beyond what can be captured through surveys alone. By allowing survey results to be analyzed through a lens of respondents’ spending data, we enable a more reality-based understanding of consumer preferences, opinions and decision-making processes. 2) Higher Marketing ROI By running survey responses against spending data, we uncover how factors like brand perception, ad exposure, or product features influence purchasing decisions within different target groups. With this knowledge, our customers refine their strategies to better resonate with specific audiences, leading to improved targeting and higher returns on investment. 3) Precision & Accuracy Utilizing consumer spending data, marketers can precisely select survey participants based on their actual spending behavior and verified demographic variables. This allows for swift construction of highly specific samples, and ensures accuracy throughout the survey process.
2019
Chairman Of The Board, EPTI Venture Builder
Sep 2019
We empower innovation. Using distributed teams to build, invest in and transform ideas globally. A venture builder crafting the companies of the future.
2018
Board Member at the Swedish Nanotech Association
Feb 2018
SwedNanoTech är en paraplyorganisation för svenska aktörer verksamma inom nanoteknik. Vi arbetar för att påverka, skapa mötesplatser och bygga broar mellan akademi, industri, näringsliv och allmänhet för en ansvarsfull och säker utveckling av nanoteknologi.
2017
Seafire AB
Board Member in the Industry Compounder Seafire
Jun 2017
2014
Member of the Board MedTech, Medical device strategy activation stockholm
May 2014
Boule Diagnostics develops and manufactures diagnostic instruments and consumables for healthcare providers worldwide. The company’s primary focus is in small to medium-sized hospitals, clinics, and laboratories in both human and veterinary diagnostics. Boule has a strong heritage when it comes to hematology diagnostics. Our blood tests help provide one of the first and most important indicators of a disease state and Boule systems play an increasingly role in helping build the infrastructure of healthcare for small and medium size patient care environments in both human and veterinary diagnostic markets. Boule operates via subsidiaries in Sweden, the USA, Mexico and Russia. The company products are sold globally primarily through more than 200 distributors and partners in more than 100 countries, supported by Boule’s own local sales and support personnel. The Boule shares are listed on Nasdaq Stockholm since 2011
Show all 8 entries ↓
Investment activity
2004–2022 · 5 investments
2004120141201712018120221
Recent (last 2 years)Earlier